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Cell migrationat the border of the neural plate in a multistep process by signals emanated from
the epidermis, neural plate and mesoderm. In this work we show for the ﬁrst time the existence of a neural
crest maintenance step which is dependent on signals released from the mesoderm. We identiﬁed
Endothelin-1 (Edn1) and its receptor (Ednra) as key players of this signal and we show that Edn1/Ednra
signaling is required for maintenance of the neural crest by a dual mechanism of cell speciﬁcation and cell
survival. We show that: (i) Ednra is expressed in prospective neural crest; (ii) loss-of-function experiments
with antisense morpholino or with speciﬁc chemical inhibitor suppress the expression of early neural crest
markers; (iii) gain-of-function experiments expand the neural crest territory; (iv) epistatic experiments show
that Ednra/Edn1 is downstream of the early neural crest gene Msx1 and upstream of the late genes Sox9 and
Sox10; and (v) Edn1/Ednra signaling inhibits apoptosis and controls cell speciﬁcation of the neural crest.
Together, our results provide insight on a new role of Edn1/Ednra cell signaling pathway during early neural
crest development.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe neural crest is a transient embryonic structure unique to ver-
tebrates that is generated at the lateral borders of the neural plate.
Neural crest delaminates from the dorsal neural tube and migrates
extensively to various parts of the embryo, where they differentiate
into a wide variety of cell types, including most of the craniofacial
skeleton, cartilage, neurons and glia of the peripheral nervous system,
connective tissue, neuroendocrine cells, and melanocytes (Le Douarin,
Kalcheim, 1999).
The induction of the neural crest integrates signals emanating from
different tissues but their relationships are still poorly understood
(Meulemans and Bronner-Fraser, 2004; Steventon et al., 2005). Signals
from the nonneural ectoderm, the paraxial mesoderm, or both, are
currently believed to be involved in the speciﬁcation of the neural
crest in different species (Bonstein et al., 1998; Mancilla and Mayor,
1996; Marchant et al., 1998; Monsoro-Burq et al., 2003; Selleck and
Bronner-Fraser, 1995). There is increasing evidence that these tissue
interactions are mediated by molecules related to the BMP family,
Wnt, FGF, retinoic acid and Notch/Delta (reviewed in Meulemans and
Bronner-Fraser, 2004; Sauka-Spengler and Bronner-Fraser, 2006;
Steventon et al., 2005).ybar@fbqf.unt.edu.ar
l rights reserved.In Xenopus and zebraﬁsh embryos the evidence indicates that the
neural plate, neural crest and epidermis are speciﬁed by a dorso-
ventral gradient of BMP activity generated by anti-BMPmolecules that
directly bind to BMPs. However, BMP signaling appears to be
insufﬁcient to induce the neural plate or the neural crest, and FGF,
Wnt or RA are also required (reviewed in Aybar and Mayor, 2002;
Meulemans and Bronner-Fraser, 2004; Steventon et al., 2005).
Endothelins and their receptors were initially known for their
involvement in the regulation of blood pressure (Yanagisawa et al.,
1988). Endothelins belong to a family of conserved 21-amino acid
peptides that includes three members encoded by different genes
(Edn1, Edn2, Edn3). Soon after discovery, it was found that mice
carrying targeted homozygous mutations for Endothelin receptor type
A (Ednra), Endothelin-1 (Edn1) or Endothelin Converting Enzyme-1
(ECE-1) were viable to term but die shortly after due to severe
defects in the formation of neural crest derivatives (Clouthier et al.,
1998; Kurihara et al., 1994; Yanagisawa et al., 1998b). It has been
shown in the mouse embryo that Edn1/Ednra is required for the
patterning process in the pharyngeal arch by controlling the
expression of Dlx6/Hand2 transcription factors (Charite et al., 2001;
Thomas et al., 1998; Yanagisawa et al., 2003) through Gαq/Gα11
proteins (Ivey et al., 2003). Ednra is expressed in the mouse embryo
in migrating cranial neural crest cells and ectomesenchymal cells in
the pharyngeal arches (Clouthier et al., 1998; Yanagisawa et al.,
1998a), while its counterpart Edn1 peptide is secreted by pharyngeal
arch ectoderm, core paraxial mesoderm and pharyngeal pouch
115M. Bonano et al. / Developmental Biology 323 (2008) 114–129endoderm (Clouthier et al., 1998; Maemura et al., 1996; Yanagisawa
et al., 1998a). The expression and function of Edn1/Ednra signaling
appears to be conserved in all gnathostomes since the pharmaco-
logical alteration of Ednra function in chick (Kempf et al., 1998) and
rat (Spence et al., 1999) embryos reproduce the distal arch effect
described for knock-out mice. In addition, the zebraﬁsh mutation of
Edn1 gene sucker (suc or suc/et1) have multiple defects that are
consistent with the patterning role of Edn1/Ednra signaling in the
pharyngeal arch (Kimmel et al., 2001, 2003; Miller and Kimmel,
2001; Miller et al., 2000, 2003). These studies have demonstrated for
the mice, chick and ﬁsh embryos that Ednra signaling is essential for
late neural crest development.
Edn1 is synthesised as a large peptide encoded by the Ppet-1 gene,
which is converted to the active peptide Edn1 by the converting
enzyme ECE-1 (Xu et al., 1994). In order to investigate the function of
Edn1/Ednra signaling pathway in Xenopus embryos, we have isolated
the Ednra, Ppet-1, and ECE-1 homologues. We found, unexpectedly, an
early expression of Ednra in the neural folds from late gastrula stage
onward. Gain- and loss-of-function experiments show that the Edn1/
Ednra signaling is involved in the early induction of the neural crest
precursors. By performing rescue experiments, we found that Ednra
function lies downstream the transcription factor Msx1 in the genetic
cascade of neural crest induction. Furthermore, we describe a new
step of neural crest development: neural crest maintenance by signals
produced by the mesoderm during mid-neurula stages. We show that
Edn1/Ednra signaling is required and sufﬁcient for this neural crest
maintenance step and that they control neural crest survival. Our
results show a new role of Edn1/Ednra signaling in early neural crest
maintenance; and we have been able to show that this step is
dependent on a dual activity of Edn1/Ednra on cell survival and cell
speciﬁcation.
Materials and methods
Isolation of Xenopus Ednra homologues
Using the human and Xenopus heart Ednra mRNA (BC022511 and
U06633, respectively) as probes, several interesting ESTs were found
at the NCBI database. We fully sequenced the clone XL061f18 from the
Mochii Xenopus tailbud library that was kindly gifted by Dr. Naoto
Ueno (NIBB, Okazaki, Japan). This clone encoding X. laevis Ednra was
deposited at NCBI Nucleotide database (DQ523688). Homology
searches were also carried out in order to isolate Xenopus laevis
Preproendothelin-1 (Ppet-1) and Endothelin Converting Enzyme-1 (ECE-
1). The screening resulted in the identiﬁcation of clones XL041d02,
originated from a neurula-stage library and XL333c19ex from a stage
10.5 dorsal marginal zone library (NIBB, Japan). These clones were
fully sequenced and deposited at NCBI Nucleotide database (EF127993
and EF127992, respectively). In order to identify and isolate unknown
Ednra genes we used X. laevis Ednra sequence to query Xenopus
tropicalis genome at JGI and Ensembl databases. Ednra homologue
sequences were initially identiﬁed using Blastn and Tblastx algo-
rithms, and the corresponding cDNAs reconstructed by means of
Wise2 (EMBL) and Spidey (NCBI) algorithms. Xenopus tropicalis Ednra
gene and cDNA were deposited at NCBI under Accession numbers
DQ865481 and DQ865482, respectively. Alignments of amino acid
sequences were done using the ClustalW algorithm. The phylogenetic
tree was drawn with the Phylodendron application from data
generated with ClustalW. Protein domains were analyzed using
SignalP, Prosite and SOSUI systems (Hirokawa et al., 1998).
Embryonic manipulation, RNA microinjection, lineage tracing and
dexamethasone induction
Embryos were obtained by standard procedures (Aybar et al.,
2003) and staged according to Nieuwkoop and Faber (1967). Tissuedissections and melanocyte induction were carried out as previously
described (Aybar et al., 2003; Bonstein et al., 1998; Honore et al.,
2003). In order to assess Ednra activity, resin or Heparin-Sepharose
beads were soaked with 5–20 μM of BQ123 or 5–20 μM Endothelin-
1 (Edn1) peptide (Sigma, USA) and grafted in embryos as previously
described (Honore et al., 2003). Soaked beads were implanted in the
right neural fold region, and the ﬁnal position of beads was carefully
examined under stereoscopic microscopy after the in situ hybridiza-
tion procedure. RNA microinjection, lineage tracing and dexametha-
sone induction was performed as described (Aybar et al., 2003).
Morpholino antisense oligonucleotide and DNA constructs
A morpholino antisense oligonucleotide (EdnraMO) was designed
against X. laevis Ednra including the initiation start site (from −5 to
+18 bp) with the following sequence 5′-CAAGGTGTTTCCTCCC-
ATCCTGATG-3′ (Gene Tools, LLC). Doses of 10–25 ng/embryo were
microinjected together with a lineage tracer into one blastomere at the
8- or 16-cell stage. A control antisense oligonucleotide composed of a
random sequence (CoMO, Gene Tools, LLC)was injected as a control. The
EdnraORF frompBSwas subcloned into a pCS2+ vector. For the rescue of
morpholino knock-down experiments a DNA constructwas prepared by
changingonly the codon sequence targeted by themorpholinoantisense
oligonucleotide. Special care was taken to mutate the sequence for one
that codes for the wild type Ednra amino acid sequence. This construct,
named Ednra′, introduced 10 mismatches in the nucleotide sequence
recognized by the morpholino and wasmade by high ﬁdelity PCR using
the following primers: 5′-ATCGATATGGGTGGTAATACGTTAAGATTC-
ACTGTG-3′ and 5′-TCTAGACTAATTGATGCTGTCCTTGTGAATAC-3′. In
order to test the efﬁcacy of EdnraMO in vivo, an Ednra–GFP fusion was
generated by high ﬁdelity PCR using pBS-Ednra as the template and the
following primers: 5′-GCGCAATTAACCCTCACTAAAGGG-3′ and 5′-
CCATGGCAAAGCCTATGGCTTCAGG-3′ (underlined, NcoI restriction
site). A fragment containing the 5′ UTR region of Ednra (178 bp) and
encoding 214 amino acid residues of Ednrawas cloned into the TOPO-TA
vector, ampliﬁed and then cloned directionally into BamHI and NcoI
pCS2-EGFP vector to produce the Ednra-GFP construct. In vitro
transcribedmRNA of this construct was coinjectedwith themorpholino
oligonucleotides.
In vitro translation and western blotting
The efﬁcacy of antisense morpholino oligonucleotide EdnraMO,
directed against Xenopus laevis Ednra, was tested in vitro. Ednra or
Ednra′ mRNA were translated in vitro using a rabbit reticulocyte
lysate (Promega, WI, USA) and the Trascend™ non-radioactive
translation detection system (Promega) in the presence of EdnraMO
or CoMO. Reactions were assembled on ice and then incubated at 37 °C
for 1.5 h. Aliquots of the reactions were separated in a 7.5% Tris–HCl
electrophoresis gel and blotted to a nitrocellulose membrane. The
membranes were blocked and incubated with Streptavidin-AP
(Sigma-Aldrich) and developed with NBT-BCIP substrate.
RNA isolation from embryos and RT-PCR analysis
Total RNA was isolated from whole embryos or embryonic tissues
after microdissection and cDNA were synthesised as previously
described (Aybar et al., 2003). The primers designed for this study
were: Ednra, 5′-GCCTTTCTTATGTAGATAGTGGG-3′ and 5′-TCTAAT-
GAGCGTTTTGCATGG-3′; Pppet-1, 5′-CCCTGGGCTGTTTATAGG-
AATGTAG-3′ and 5′-GTTTCTCTTGGTCAGTGTCCTGC-3′; ECE-1, 5′-
TGCACAAGTCTGGTGTACTGTG-3′ and 5′-CCTTTCATACAGTC-
TGGCAGTG-3′. PCR ampliﬁcation with these primers was performed
over 29 cycles and the PCR products were analyzed on 1.5% agarose
gels. As a control, PCR was performed with RNA that had not been
reverse-transcribed to check for DNA contamination.
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immunohistochemistry
Antisense probes containing Digoxigenin-11-UTP or Fluorescein-
12-UTP were prepared for Ednra (digested with EcoRV from pBS
vector, transcribed with T7), Sox10 and Sox9 (Honore et al., 2003),
Sox2 (Dr. RM Grainger, personal communication), cytokeratin Xk81A(Jonas et al., 1985; Mayor et al., 1995), Snail2 (Mayor et al., 1995),
Snail1 (Essex et al., 1993), FoxD3 (Sasai et al., 2001), and Trp-2 (Aoki
et al., 2003) by in vitro transcription. Specimens were prepared,
hybridized, and stained as previously described (Aybar et al., 2003;
Tribulo et al., 2003). Apoptosis was detected by TUNEL staining
according to the procedure previously described (Hensey and Gautier,
1998; Tribulo et al., 2004). For cartilage staining, embryos were ﬁxed
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al., 2004). Rabbit Polyclonal anti-phosphohistone-3 (Upstate Biotech-
nology) was used to analyze mitotic cells according to the method
previously described (Aybar et al., 2003; Turner andWeintraub,1994).
Results
Isolation of embryonic Xenopus laevis Ednra
A cDNA of an Endothelin receptor was previously isolated from the
heart of adult Xenopus frogs (ETAX, genbank:U06633; (Kumar et al.,
1994), but there was no indication that an Endothelin receptor is
expressed in Xenopus embryonic tissues. To clone the X. laevis Ednra
cDNA expressed during embryonic development we performed a
homology search in EST databases at the NCBI. The cDNA isolated
(clone XL061f18) was 2832 bp in length and contained an open
reading frame encoding a 415 amino acid residues protein (Supple-
mental data, Fig. S1, A, B). Sequence analysis revealed a novel Ednra
isoform and predicted seven transmembrane domains and a topology
of G protein-coupled superfamily of receptors (Fig. S1, A). Xenopus
embryonic Ednra cDNA (genbank:DQ523688) shares 94% amino acid
identity and 90% nucleotide identity with Xenopus ETAX. (Kumar et al.,
1994), 66% and 51% amino acid identity with Xenopus Ednrb and Ednrc
(Karne et al., 1993). In order to identify unknown Ednra genes for the
phylogenetic analysis we searched Xenopus tropicalis genomic
databases. The gene structure comparison for X. tropicalis (Supple-
mental data, Table 1S, Fig. S1, C) and human Ednra (Livingston et al.,
2004) revealed a high conservation of the overall 8-exon structure and
exon sizes despite differences in the entire length of these genes
(Supplemental data, Fig. S1C–D, Table 2S). On the basis of the data
obtained from the comparison of different Ednra proteins, we built the
unrooted phylogenetic tree of vertebrate Ednra that illustrates clearly
the relatedness of these receptor proteins (Fig. 1A).
The expression pattern of Ednra was analyzed by RT-PCR (Fig. 1B)
and whole-mount in situ hybridization (Figs. 1C–O). No maternal
expression of Ednra was observed, and the transcripts were ﬁrst
detected by RT-PCR from stage 12 (Fig.1B), and by in situ hybridization
from the late gastrula stage restricted only to the ectoderm, in two
faint patches at the anterior-lateral sides of the neural plate (Fig. 1C).
At mid-neurula stage (stages 14–18) Ednra expression is observed in
the prospective cranial and trunk neural crest cells (Figs. 1D, F)
throughout neurulation, showing a similar pattern to the neural crest
marker gene FoxD3 (Fig. 1E). Double in situ hybridization showed that
this expression is complementary and not overlapping with the neural
plate marker Sox2 (Figs. 1F, G). As development continues, neural crest
cells initiate their migration and the expression of Ednra is detected in
the cranial migrating neural crest, the otic placode and in the trunk
region (Figs. 1K–O). We conclude that Ednra is expressed in the
premigratory and migratory neural crest.
Edn1/Ednra signaling is required for neural crest development
Ednra expression pattern strongly suggests that Edn1/Ednra
signaling is involved in neural crest development. To analyze theFig. 1. Xenopus laevis Endothelin-1 receptor type A features and expression pattern. (A) Molec
Ednrb and with Ednra from different vertebrate species. The protein sequences of differen
neighbour-joining analysis. Xenopus laevis Ednrb, Danio rerio EdnrA1, and Danio rerio EdnrA2 b
Ppet-1, and ECE-1 during different developmental stages. Total RNA isolated from stages 1,10.5
andmethods. Contamination of genomic DNAwas examined by experiments without RT reac
control. (C–L) Expression pattern of Xenopus laevis Ednra. (C) Ednra transcripts are ﬁrst detec
During neurulation Ednra is expressed in the prospective cephalic (asterisk) and trunk neur
Ednra (purple) and Sox2 (turquoise). (G) Transverse section of (F). Asterisk, prospective neur
neural crest (arrowheads), trunk region (arrow), crest cells migration into dorsal ﬁn (white a
vesicle (OtV) and the neural crest hyoid migratory stream (arrowheads). NT, neural tube; n,
arrowheads), cells into the dorsal ﬁn (white arrowheads), and otic vesicle (OtV). OpV, optic ve
of the otic vesicle (arrowheads). (L) Horizontal section showing Ednra expression (arrowhea
(asterisks).function of Ednra, we designed an antisense morpholino oligonucleo-
tide directed against the start codon of Ednra (EdnraMO). This
morpholino oligonucleotide inhibited translation of a GFP-tagged
form of Ednra in a dose-dependent manner in vitro (Fig. 2A) and in
vivo (Figs. 2B–I). We decided to investigate the development of some
neural crest derivatives after injection of Ednra morpholino antisense
oligonucleotides. Control side of the embryos show the normal
melanocyte pattern (Fig. 2J), and normal expression of themelanocyte
precursor marker Trp2 (Fig. 2M), while in EdnraMO-injected embryos
Trp2marker and melanocyte formationwere inhibited (Fig. 2K, 38% of
embryos with melanocytes, n=50; Fig. 2N, 25% of embryo with Trp2
expression, n=66). A similar inhibition was observed in vitro.
Melanocytes were induced in vitro by conjugating animal caps with
prospective paraxial mesoderm taken from early gastrula embryos
(Fig. 2O, 81%, n=22); while conjugates made in the presence of the
Ednra-inhibitor BQ123 showed no melanocytes formation (Fig. 2P,
76%, n=25). Cartilage development was also analyzed. A severe loss or
reduction of craniofacial cartilages was observed in the EdnraMO-
injected side by Alcian Blue staining (Fig. 2Q, 66% of the embryos;
n=27). The gross morphology analysis of cranial cartilages revealed
that Meckel's and ceratohyal cartilages were markedly reduced, and
branchial cartilage was mildly affected (Fig. 2R). These results show
Edn1/Ednra signaling is required for the normal formation of neural
crest derivatives such as melanocyte and cartilage.
Ednra is required for the early formation of neural crest cells
The Ednra expression pattern and the effects of EdnraMO or
BQ123-treatment suggest Ednra-mediated signaling is required
during early neural crest development. In order to evaluate the
participation of Edn1/Ednra signaling during neural crest induction,
embryos were injected at the four- or eight-cell-stage in one dorsal
blastomere with EdnraMO (25 ng/embryo) or an equivalent amount of
a control morpholino (CoMO) (Figs. 3A–I). The embryos injected with
CoMO showed normal morphology and expression of Snail2 (Figs. 3F,
I), while embryos injected with EdnraMO failed to form a neural fold
and showed a clear inhibition of Snail2, FoxD3 and Snail1 expression
at the injected side (Fig. 3A, 75%, n=120; Fig. 3B, 72%, n=98; Snail1 not
shown, 71%, n=32 of inhibition). The neural plate markers Sox2 (Fig.
3C, 64%, n=31) and Sox3 (66%, n=45; not shown) and the epidermal
marker XK81a were expanded (Fig. 3D, 69% of expansion, n=27). The
effect on neural plate and epidermal markers could be a consequence
of the absence of neural crest at the border of each tissue, as no
overlapping of neural plate and epidermis was observed (Fig. 3E).
These results show that Ednra depletion leads to a speciﬁc loss of
neural crest progenitors, thus suggesting that Ednra is involved in the
early speciﬁcation of the neural crest cells.
To assess the speciﬁcity of the morpholino effects, we asked
whether the phenotype of Ednra-depleted embryos could be rescued
by restoring Ednra function. We injected an Ednra construct (Ednra′)
carrying a 10 bp mutation within the recognition motif of EdnraMO in
order to avoid hybridization between the morpholino and the
microinjected mRNA. Injection of Ednra′ mRNA shows an expansion
of Snail2 expression in 53% (n=51) of the embryos (Fig. 3H),ular phylogenetic analysis of Ednra shows the relationship with Xenopus ETAX, Xenopus
t Ednra were analyzed using ClustalW 1.81, and an unrooted tree was constructed by
ranches are collapsed 50%. (B) RT-PCR analysis of temporal expression pattern of Ednra,
, 12, 14,18, and 21was isolated, retrotranscribed and ampliﬁed as described inMaterials
tions (−RT) using total RNA from stage 18 embryos. EF1α expressionwas used as loading
ted from late gastrula stage (St. 12.5) in the lateral domains of neural plate (arrows). (D)
al crest (arrows). (E) In situ hybridization for FoxD3. (F) Double in situ hybridization for
al crest. (H) Tailbud-stage (St. 24) embryo showing expression in the migrating cephalic
rrowheads), and otic vesicle (OtV). (I) Frontal section of (H), Ednra expression in the otic
notochord. (J) A St. 30-embryo showing Ednra expression in the branchial arches (black
sicle. (K) Section showing Ednra expression in the dorsomedial and ventromedial region
ds) in the ﬁrst and second pharyngeal arches surrounding the central mesodermal core
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However, when EdnraMO was coinjected with Ednra′ mRNA a strong
rescue in Snail2 expression (Figs. 3G, I), and in melanocytes (Fig. 2L)
and cartilage development (Fig. 2S) was observed. This effect wasspeciﬁcally produced by the coinjection of Ednra′mRNA but not by the
coinjection of unrelated mRNAs like GFP mRNA (not shown). Thus, we
conclude that EdnraMO was able to speciﬁcally knock-down Ednra
activity.
Fig. 3. Ednra is required for early neural crest speciﬁcation. (A–I) Effect of EdnraMO on neural crest speciﬁcation. Arrows indicate the injected side. (A'–D') Transverse sections of
embryos at the level of cephalic neural crest. (A, B) Ednra-depleted embryos fail to express neural crest markers Snail2 (A) and FoxD3 (B). (A, B, insets) The injected side is recognized
by the ﬂuorescence of the lineage tracer FLDx. (C, D) Expression of neural plate marker Sox2 and epidermal marker XK81a is expanded on the EdnraMO-injected side. (E) Embryo
processed by double in situ hybridization for Sox2 and XK81a genes showing the reduction of prospective neural crest domain in the injected side. (F) Injection of control morpholino
(CoMO) showed no effect. (G) Coinjection of EdnraMO and Ednra′ mRNA rescues Snail2 expression. (H) Single injection of Ednra′ mRNA expanded the Snail2 expression domain. (I)
Quantiﬁcation of rescue experiments. Results are expressed as percentage of embryos normally expressing Snail2 for each treatment (yellow bars), and as percentage of embryos
showing reduced Snail2 expression (purple bars). Two different concentrations of Ednra′ mRNA were coinjected for rescue experiments (0.5 ng/embryo and 0.9 ng/embryo). (J–N)
Ednra participates in the early neural crest speciﬁcation. Ednra-injected embryos show increased expression of Snail2 (J) and FoxD3 (K). Expression of the neural plate marker Sox2 (L)
and epidermal marker XK81a (M) are reduced on the injected side. (N) Double in situ hybridization for Sox2 and XK81a shows the enlargement of prospective neural crest territory in
the injected side. Broken line, dorsal midline; brackets indicate the width of the neural plate (C, L), the width of neural crest domain (E, N) or the width of the neural plate plus the
neural crest domain (D, M).
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of neural crest speciﬁcation we microinjected Ednra mRNA in the
animal pole of a dorsal blastomere at four to eight-cell stage embryos.Fig. 2. Ednra is required for neural crest development. (A–I) Efﬁciency of Ednra antisense m
dependent fashion. Arrow indicates Ednra protein product. (B–I) EdnraMO inhibits in vivo e
embryo) showing GFP ﬂuorescence. (D,E) Embryos injected with Ednra–GFP mRNA (1 ng/em
embryo) and EdnraMO (F–G, low dose, (l) 10 ng/embryo; H–I, high dose (h), 20 ng/embryo). N
(J–S) Analysis of the formation of neural crest derivatives. Normal melanocyte formation (J, a
melanocyte development (K) or Trp2 expression (N). The melanocyte formation was com
melanocytes in vitro by conjugating animal caps with prospective paraxial mesoderm cult
Conjugates prepared with a 10 μMBQ123-soaked bead show nomelanocyte formation (P). Ed
cartilages. (R) Schematic representation of EdnraMO effects on Xenopus head cartilages. M, M
Normal cartilage formation was completely rescued by the coinjection of EdnraMO and EdnThe injection of Ednra leads to an expansion of the neural crest
territory analyzed by the expression of Snail2 (66%, n=33), FoxD3
(65%, n=40) (Figs. 3J, K), and Snail1 (not shown, 73%, n=41), and aorpholino oligonucleotide. (A) EdnraMO inhibits in vitro translation of Ednra in a dose-
xpression of Ednra–GFP. (B,C) Embryos injected with mRNA encoding Ednra–GFP (1 ng/
bryo) and CoMO (30 ng/embryo). (F–I) Embryos injected with Ednra–GFP mRNA (1 ng/
o embryo shows GFP ﬂuorescence at high dose. White arrows indicate the injected side.
rrows) and Trp2 expression (M, arrows). EdnraMO-injected embryos show inhibition in
pletely rescued by the coinjection of EdnraMO and Ednra′ mRNA (L). Induction of
ured until the equivalent of St. 38. Control conjugates show melanocytes (O, arrows).
nraMO-injected (Q, arrowhead) embryos present a reduction of Meckel's and ceratohyal
eckel's cartilage; Ir, infrarrostral; CH, ceratohyal; BH, basihyal; CB, ceratobranchial. (S)
ra′ mRNA.
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sion (60%, n=35, Figs. 3L–N). These observations suggest that the
expansion of the neural crest as a result of the ectopic expression of
Ednra is produced by the transformation of the epidermis and some
of the neural plate region into prospective neural crest cells.Fig. 4. Temporal requirement of Edn1/Ednra signaling for neural crest induction. Stage 12 (A–
soaked bead or with the speciﬁc Ednra-inhibitor BQ123. Embryos were cultured until stage
indicate the grafted side. Red circles indicate the position of Edn1- or BQ123-soaked beads.
and FoxD3 (B, L). The marker Sox2 (C) and XK81a are reduced (D). (S) No changes in the ex
embryos. (E–H, N–P) BQ123 leads to a reduction in the expression of neural crest markers Fo
the expression of Sox2 (P). (I–J, Q–R) Control embryos grafted with BSA-soaked bead. No eff
observed.Temporal requirement of Edn1/Ednra signaling for neural crest induction
Antisense morpholino treatments are very speciﬁc for the
inhibition of a particular gene. However, it is more difﬁcult to control
the time of its activity. In order to control the time of Edn1/EdnraJ), 14 (K–R) or 16 (S) embryoswere grafted on the right neural fold with an Edn1 peptide-
14 (A–J) or 18 (K–S), when the expression of marker genes was analyzed. Arrowheads
(A–D, K–M) Edn1 peptide increases the expression of neural crest markers Snail2 (A, K)
pression of FoxD3 were observed when Edn1-soaked beads were grafted into stage-16
xD3 (E, N) and Snail2 (F, O) on the treated side. BQ123 treatment produces an increase in
ect on the expression of neural crest (I, Q; FoxD3) or neural plate (J, R; Sox2) markers is
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Ednra-speciﬁc antagonist BQ123. Three different stages of develop-
ment were tested in their ability to respond to Edn1/Ednra signaling.
Beads soaked with different amounts of Edn1 or BQ123 were
implanted next to the right prospective neural crest of stage-12
(Figs. 4A–J), or stage-14 embryos (Figs. 4K–R), and beads soaked with
Edn1 were implanted at stage-16 embryos (Fig. 4S). Embryos were
cultured until stage 14 (Figs. 4A–H) or stage 18 (Figs. 4K–R), and the
expression of different markers was analyzed by in situ hybridization.
Treatment of stage 12 embryos with Edn1-soaked beads produced a
moderate increase in the expression of neural crest markers Snail2,
FoxD3 (Figs. 4A–B, 62%, n=34; 65%, n=57; respectively) and Snail1
(not shown, 82%, n=28). This effect was accompaniedwith a reduction
in the expression of the neural plate marker Sox2 (Fig. 4C, 57%, n=28)Fig. 5. Edn1/Ednra signaling is necessary for neural crest maintenance. (A) Schematic rep
explants dissected out for the experiments. Blue, neural crest; red, mesoderm: s, paraxial mes
explants (NC) were prepared by dissection of the neural crest (−M), or by including the under
FoxD3 (H). NC(−M) explants dissected from stage 16-embryos and cultured until equivalent s
16-embryos and cultured until stage 22, express Snail2 (D) and FoxD3 (J) markers. NC(−M) ex
and FoxD3 (L) expression. In NC(+M) explants cultured in 10 μM BQ123 the expression of Sn
equivalent stage 22 in 10 μM Edn1 peptide. No expression of Snail2 (E) or FoxD3 (K) was inand the epidermal marker XK81a (Fig. 4D, 64%, n=33). Treatment of
stage-12 embryos with 10 μM BQ123 markedly downregulated FoxD3
(Fig. 4E, 78%, n=32) and Snail2 (Fig. 4F, 77%, n=53) expression in the
neural crest territory. The inhibitor BQ123 produced an increase on
the expression of genes Sox2 (Fig. 4G, 59%, n=33) and XK81a (Fig. 4H,
68%, n=38) expressed in tissues adjacent to neural crest. No effect on
the expression of the neural crest marker FoxD3 or the neural plate
marker Sox2 was observed when BSA-soaked beads were grafted
(Figs. 4I, J). Thus, the pharmacological blockade by BQ123 is able to
reproduce the phenotype produced by the morpholino knockdown
showing that Ednra activity is required for neural crest induction.
Similar, but weaker, effects were observed when stage-14 embryos
were used. Edn1-soaked beads lead to an increase in the expression of
neural crest markers FoxD3 (Fig. 4K, 64%, n=45), Snail2 (Fig. 4L, 65%,resentation of transverse section mid-neurula embryos and the different neural crest
oderm; IM, intermediatemesoderm; orange, notochord; yellow, endoderm. Neural crest
lying mesoderm (+M). NC explants dissected at stage 16-embryos express Snail2 (B), and
tage 22 have lost Snail2 (C) and FoxD3 (I) expression. NC(+M) explants taken from stage
plants cultured in 10 μM Edn1 peptide until equivalent stage 22 show positive Snail2 (F)
ail2 (G) and FoxD3 (M) was inhibited. Control animal cap explants were cultured until
duced.
Fig. 6. Analysis of Ppet-1 and ECE-1 expression. (A) RT-PCR analysis of the expression of
Ednra, Ppet-1 and ECE-1 in neural crest and mesodermal explants. Explants were
dissected out from stage-16 embryos (see Materials and methods). E, stage-16 embryo;
AC, animal caps; NC, neural crest explants; M, mesodermal explants. EF1α, loading
control. (B–C) Expression pattern of Xenopus laevis Preproendothelin-1 and Endothelin
Converting Enzyme-1. (B) Preproendothelin-1 (Ppet-1) transcripts are detected by whole-
mount in situ hybridization during mid-neurula stage (St. 16) in the mesoderm. (B')
Transversal section of (B), Ppet-1 is expressed in somite (s) and lateral mesoderm
(asterisk). The broken line indicates the tissues that were dissected out for the isolation
of neural crest explants containing the mesoderm underlying the neural crest (see Fig.
5). (C) Endothelin Converting Enzyme-1 (ECE-1) is expressed during mid-neurula stage
(St. 16) in the dorsal ectoderm and mesoderm. (C') Transversal section of (C). s, somite;
n, notochord.
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Sox2 expression (Fig. 4M, 64%, n=33). Treatment with BQ123 slightly
but consistently affected FoxD3 (Fig. 4N, 71%, n=35) and Snail2 (Fig.
4O, 58%, n=32) expression. Expression analysis of the neural plate
marker Sox2 in these embryos showed that the neural plate was
expanded (Fig. 4P, 51%, n=35). Control beads soaked in BSA had no
effect on gene expression at any stage and the embryos developed
normally (Figs. 4Q, R). At this stage, the inhibition of Ednra was not
able to completely downregulate the expression of the neural crest
markers analyzed. When Edn1-soaked beads were implanted in the
neural fold of stage-16 embryos, no changes were observed in the
expression of neural crest marker FoxD3 (Fig. 4S, 83%, n=31). Taken
together, these experiments show that neural crest speciﬁcation by
Edn1/Ednra takes place between late gastrula (stage 12) and early
neurula stage (stage 14), suggesting the existence of a new step of
neural crest induction later that the one initially described (Mancilla
and Mayor, 1996).
Edn1/Ednra signaling is necessary for the maintenance of neural crest
speciﬁcation
There is strong evidence that the mesoderm plays an important
role in neural crest induction (Bonstein et al., 1998; Mancilla and
Mayor, 1996; Marchant et al., 1998; Monsoro-Burq et al., 2003; Raven
and Kloos, 1945). As our previous temporal analysis of neural crest
speciﬁcation by Edn1/Ednra suggest that this signaling pathway could
play a late role on neural crest induction, we decided to analyze
whether there was a late requirement of mesoderm for the
speciﬁcation of the neural crest, and if Edn1/Ednra was involved in
this late step.
Snail2 and FoxD3 are expressed in neural crest explants dissected
at stage 16 and ﬁxed immediately (Figs. 5A, B, H). However, when
equivalent neural crest explants (NC−M) are cultured in vitro until the
equivalent of stage 22, the expression of both neural crest markers
Snail2 (Fig. 5C) and FoxD3 (Fig. 5I) is lost. On the contrary, when the
cultured neural crest contained the adjacent mesoderm (NC+M) an
almost normal expression of both markers was observed (Figs. 5D, J).
This observation suggests that neural crest requires a signal from the
mesoderm to maintain its speciﬁcation. However, when NC+M
explants are incubated with the inhibitor BQ123 a clear inhibition of
neural crest markers was observed (Figs. 5G, M). Furthermore, the
addition of Edn1 is sufﬁcient to maintain neural crest markers
expression in vitro in absence of mesoderm (Figs. 5F, L). However,
the addition of Edn1 peptide to competent animal caps is not able to
induce the expression of neural crest markers (Figs. 5E, K). Taken
together, these ﬁndings indicate that Edn1 can replace the main-
tenance signal produced by the mesoderm and that Ednra activity is
essential for neural crest maintenance by the mesoderm.
As these results suggest that an Edn1 signaling produced by the
mesoderm is required for neural crest maintenance, we decided to
analyze the expression of all the components required to have a fully
active Edn1 signaling. We cloned the Preproendothelin-1 (Ppet-1) and
Endothelin Converting Enzyme-1 (ECE-1) from Xenopus laevis which
are required for Edn1 secretion and processing. Our high stringency
homology search resulted in the isolation of Ppet-1 and ECE-1 cDNAs.
Ppet-1 shared protein sequence similarity ranging 54% to 60% among
vertebrate homologues (Supplemental data, Table 3S). However, the
protein sequence of Edn1 active peptide (Supplemental data, Fig. 2S)
shares 100% identity with human, rat, mice, porcine, and bovine Edn1
peptides. The temporal expression proﬁle of Ppet-1 transcripts was
analyzed by RT-PCR (Fig. 1B). Maternal expression of Ppet-1 was not
detected and the zygotic expression was ﬁrst detectable at a low level
at stage 10.5 and expression gradually increased up in later stages. We
also analyzed by RT-PCR the expression of Ppet-1, Ednra and ECE-1 in
neural crest and mesoderm explants dissected from embryos at stage
16 (Fig. 6A). NC explants expressed Ednra and ECE-1, and themesoderm underlying the neural crest expressed Ppet-1 and ECE-1.
The analysis of spatial expression pattern by whole-mount in situ
hybridization was more difﬁcult as Ppet-1 and ECE-1 are expressed at
relatively low levels. We detected Ppet-1 transcripts predominantly in
the somitic and lateral mesoderm of mid-neurula embryos adjacent
neural crest (Figs. 6B, B') and ECE-1 transcripts in ectodermal and
mesodermal tissues (Figs. 6C, C'). These observations allow to propose
that Edn1 signal could be secreted by the mesoderm underlying the
neural crest and processed by the ECE-1 produced by tissues adjacent
to the neural crest cells.
Edn1/Ednra signaling controls the apoptosis in the neural crest
It has been previously proposed that the inhibition of apoptosis
could be necessary for the maintenance of neural crest progenitors
(Honore et al., 2003; Light et al., 2005; Tribulo et al., 2004). We
therefore decided to analyze whether Edn1/Ednra participates in the
maintenance of neural crest throughout the inhibition of the
apoptosis. A marked increase in the number of cells stained by
TUNEL was observed in the neural fold of EdnraMO-injected embryos
(Fig. 7A, 78% of embryos with increase in TUNEL staining, n=98, and
Supplemental Fig. S4,B), while no effect was observed when TUNEL
assay was performed before the onset of Ednra expression (inset in
Fig. 7A', 0%, n=25) or in embryos injected with CoMO (0% of increase
in TUNEL staining, n=55, not shown). This increase in the number of
apoptotic cell by EdnraMO injection was reversed by coinjection of
Ednra′ mRNA (Fig S4C, 16%, n=32). The microinjection of EdnraMO
produced no detectable changes in the cell proliferation status
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(Supplemental Fig. 4S,A, A').
We next asked whether apoptosis levels in neural crest explants
depends on the presence of mesodermal tissue and Edn1/Ednra
signaling. We analyzed TUNEL staining in neural crest explants that
were dissected and cultured as previously described. We found
moderate levels of TUNEL staining in explants ﬁxed at stage 16,immediately after dissection (Fig. 7B) that are in accordance to the
pattern normally observed in vivo (Tribulo et al., 2004). A higher level
of apoptotic nuclei was observed in neural crest explants (NC−M) that
were cultured until stage 22 (Figs. 7D, H), whereas apoptosis remained
at lower levels in the explants that contained mesoderm (Figs. 7E, H).
However, when NC−M explants were cultured with Edn1, a dramatic
reduction of TUNEL-positive nuclei was observed (Figs. 7F, H). In
contrast, the levels of apoptosis increased in NC+M explants by
incubation in BQ123 (Figs. 7G, H). As controls, animal cap explants
cultured in Edn1 (Fig. 7C) or BQ123 (not shown) showed that
apoptosis was not inﬂuenced by these treatments. In conclusion,
these results strongly suggest that in the neural crest Edn1/Ednra
signaling can act as an anti-apoptotic factor, and that mesoderm
instructively signals over ectoderm to maintain neural crest survival.
The previous results suggest that Edn1/Ednra control neural crest
speciﬁcation by allowing the survival of the induced neural crest cells.
Thus, the absence of neural crest markers after inhibition of Ednra
signaling could be explained by the apoptosis of the neural crest cells.
Alternatively, Ednra could control cell speciﬁcation independently of
cell survival. To distinguish the effects of blocking Ednra on
speciﬁcation from those on cell survival, we activated an inducible
Snail2 (Snail2GR) construct after stage 14 which affects apoptosis
without any effect on neural crest speciﬁcation (Tribulo et al., 2004).
Alternatively, we also used a Xenopus Bcl2 homologue (Tribulo et al.,
2004) that acts as an anti-apoptotic factor in the neural crest (Tribulo
et al., 2004). Snail2GR and XBcl2 successfully inhibited apoptosis in
neural crest explants regardless the underlying mesodermal tissue
was included or not, or whether the explants were treated with Edn1
and BQ123 (Figs. 8A–F, K–N, S). Next, we analyzed the expression of
neural crest marker FoxD3 under the same conditions (Figs. 8G–J, O–
R). We found in apoptosis-inhibited explants the same effects of Edn1
and BQ123 on neural crest expression markers, than when apoptosis
was not inhibited. Absence of mesoderm leads to the disappearance of
FoxD3 (Figs. 8G, O), which is rescued by Edn1 treatment (Figs. 8I, Q);
while neural crest maintenance by mesoderm (Figs. 8H, P) is inhibited
by BQ123 treatment (Figs. 8J, R). In conclusion, the effect of Edn1/
Ednr1 signaling on neural crest cell death can be dissociated from its
effect on cell speciﬁcation. Taken together, our results show that the
Edn1/Ednra signaling plays a dual role on neural crest development:
cell speciﬁcation and cell survival.
Ednra is downstream Msx1 in the genetic cascade that speciﬁes neural
crest cells
Having established that Edn1/Ednra signaling is involved in the
early speciﬁcation of the neural crest we decided to investigate the
hierarchical relationship between Ednra and other members of the
neural crest genetic cascade. The different genes involved in neural
crest development have been grouped into three categories: early
neural plate border speciﬁers, neural crest speciﬁers or survival genesFig. 7. Edn1/Ednra signaling controls the apoptosis in the neural crest. (A) EdnraMO-
injected embryos show increased TUNEL staining (arrowhead, injected side; A', FLDx
lineage tracer). (A', inset) EdnraMO-injected embryos show no increase of TUNEL
labeling at stage 12, indicating that apoptosis was not induced bymorpholino toxicity at
stages when Ednra is not expressed. (B) Neural crest (NC) explants taken from stage 16-
embryos and immediately ﬁxed show moderate level of TUNEL staining. (C) Control
animal cap explants cultured until equivalent stage 22 in 10 μM Edn1 show no
inhibition of normal apoptosis. (D) NC(−M) explants dissected at stage 16 and cultured
until stage 22 show increased apoptosis. (E) NC(+M) explants show a moderate
inhibition of apoptosis. (F) NC(−M) explants treatedwith 10 μMEdn1 show inhibition of
TUNEL staining. (G) NC(+M) explants cultured with 10 μM Ednra-speciﬁc inhibitor
BQ123 show increased number of TUNEL-positive apoptotic nuclei. (H) Quantiﬁcation of
apoptosis in neural crest explants. Results are expressed as number of apoptotic nuclei/
explant±S.D. Control refers to the TUNEL staining of stage 16-embryos. Every condition
or treatment, except NC(+M) explant, was signiﬁcantly different from control explants
(Student's t-test, Pb0.001). (⁎) NC(−M)+Edn1 was statistically different from NC(−M),
Pb0.001. (⁎⁎) NC(+M)+BQ123 was statistically different from NC(+M), Pb0.001.
Fig. 8. The Edn1/Ednra signaling control on the maintenance of neural crest speciﬁcation can be dissociated from apoptosis. (A) Snail2GR-injected neural crest (NC) explant dissected
out and ﬁxed at stage 16. In control explants the Snail2GR inducible construct was not activated. Explants show the normal apoptotic pattern. (B) Control animal cap explants cultured
until equivalent stage 22 in 10 μMEdn1 show no inhibition of normal apoptosis. NC(−M) or NC(+M) explants from Snail2GR-injected embryos (C–J) and XBcl2-injected embryos (K–R)
were dissected at stage 16 as indicated in Fig. 5A. Snail2GR construct was activated at stage 16 by adding dexamethasone (10 μM ﬁnal concentration). Explants were processed for
TUNEL staining (C–F, K–N) or in situ hybridization (G–J, O–R). (C–F, K–N, S) All Snail2GR- and XBcl2-injected explants show a marked inhibition of apoptosis, regardless the presence
or not of mesodermal tissue into the explant, or the incubationwith 10 μMEdn1 peptide or 10 μMBQ123. The expression of FoxD3was lost in Snail2GR-injected and XBcl2-injected (G,
O; respectively) NC(−M) explants. In Snail2GR-injected and XBcl2-injected NC(+M) explants the expression of FoxD3 marker was maintained (H, P; respectively). Snail2GR-injected
and XBcl2-injected NC(−M) explants incubated in 10 μM Edn1 show the expression of FoxD3 (I, Q; respectively). Snail2GR-injected and XBcl2-injected NC(+M) explants incubated in
10 μM BQ123 failed to express FoxD3marker (J, R). (S) Quantiﬁcation of apoptosis in Snail2GR and XBcl2-injected neural crest explants. Results are expressed as number of apoptotic
nuclei/explant±S.D. Control refers to the TUNEL staining of NC explants taken from stage 16-embryos. Every condition or treatment in Snail2GR-injected explants was signiﬁcantly
different from control explants (⁎, Pb0.001). XBcl2-injected NC(−M) and NC(+M) explants were statistically different from control, Pb0.001. (⁎⁎) XBcl2-injected NC(−M)+Edn1 and
NC(+M)+BQ123 explants were statistically different from control, Pb0.01.
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Steventon et al., 2005). We choose Msx1 as a neural plate border
speciﬁer and Sox9 and Sox10 as neural crest speciﬁer to analyze the
hierarchical position of Ednra in the genetic cascade. Representative
examples of embryos injected with the indicated reagents are shown
in Figs. 9A–O, and the percentage of effect for each experiment is
shown in the graphs of Fig. 9. Injection of anMsx1-inducible construct,
Msx1-GR, leads to an increase in the expression of Ednra (Fig. 9A, 71%,n=41) that correlates with the increase in FoxD3 expression (Fig. 9B,
68%, n=44), while an inducible dominant negative of Msx1, HDMsx1-
GR, produces a reduction in Ednra (Fig. 9D, 68%, n=52) and FoxD3
expression (Fig. 9E, 66%, n=47). The inhibition of FoxD3 (Fig. 9E) by
HDMsx1-GR injection was almost completely rescued by the coinjec-
tion of Ednra (Fig. 9F, 85%, n=59). Furthermore, the expansion of the
neural crest markers by injection ofMsx1-GR (Fig. 9B) was reversed by
coinjection with EdnraMO (20 ng/embryo, Fig. 9C; 78%, n=46). The
Fig. 9. Ednra in the genetic cascade that speciﬁes the neural crest. Ednra lies downstreamMsx1 and upstream Sox9–Sox10. (A–O) Representative examples of embryos injected with
the indicated reagents. The graphs at the right side represent the percentage of embryos with the indicated phenotypes; the letter in each column correspond to the treatment
described for each ﬁgure in panels A–O. (A, B) Embryos injected with Msx1-GR show increased expression of Ednra and neural crest marker FoxD3. (C) Msx1-GR construct failed to
increase the expression of FoxD3 marker when was coinjected with EdnraMO. (C') EdnraMO leads to a reduction of FoxD3 expression in the injected side (arrowhead). (D, E) Msx1-
dominant negative inducible construct (HDMsx1-GR) inhibited the expression of Ednra and FoxD3. (F) The coinjection of dominant negative HDMsx1-GR construct and Ednra mRNA
rescue the expression of FoxD3 in the neural crest. (F') Ednra overexpression leads to an increased FoxD3 expression in the injected side (arrowhead). (G) No changes in the expression
of Msx1 was observed in embryos microinjected with Ednra mRNA. (H, I) Ednra mRNA-microinjected embryos show expanded expression of Sox9 and Sox10 in the injected side
(arrowhead). (J–L) EdnraMO-microinjected embryos show no effect on Msx1 (J), but inhibition of Sox9 (K) and Sox10 (L) expression in the injected side (arrowhead). (M–O) Sox9
mRNA and Sox10 mRNA rescue FoxD3 expression in EdnraMO-injected embryos. (N') Expansion of FoxD3 in embryo injected with Sox9. (O') Expansion of FoxD3 in embryo injected
with Sox9.
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(Fig. 9G; 94%, n=44) or EdnraMO (Fig. 9J; 87%, n=31). Taken together,
these observations indicate thatMsx1 is upstream Ednra in the genetic
cascade that speciﬁes the neural crest in the ectoderm.
We then analyzed the relationship of Ednra with Sox9 and Sox10
genes, two genes that have been proposed to be downstream of the
early neural crest genes Msx1 and Pax3 (Steventon et al., 2005). Sox9
(Fig. 9H, 62%, n=40) and Sox10 (Fig. 9I, 75%, n=41) expressions were
increased when EdnramRNAwas injected in 4–8-cells stage and were
reduced by the injection of EdnraMO (Fig. 9K, 79%, n=61, and Fig. 9L,
67%, n=55, respectively). The effect of EdnraMO on FoxD3 (Fig. 9M)
was rescued by the coinjection of Sox9 (Fig. 9N, 63%, n=51) or Sox10
(Fig. 9O, 77%, n=46). Thus, these results suggest that Sox10 and Sox9
activities are likely to be downstream Edn1/Ednra activity in
specifying the neural crest progenitors.Edn1/Ednra signaling is required for neural crest migration
Ednra is expressed both in the premigratory and migratory neural
crest. This fact suggests Edn1/Ednra signaling might be controlling
the migratory process. When Edn1/Ednra signaling was inhibited by
EdnraMO (Fig. 10B; Snail2 55%, n=50) a clear inhibition in neural
crest migration was observed. However, in order to observe this
phenotype we had to analyze only the embryo that had a weak
phenotype in neural crest speciﬁcation, as an effect on neural crest
induction could affect neural crest migration. In order to directly test
neural crest migration we activated or inhibited Edn1 signaling, with
Edn1 or BQ123 soaked bead respectively, at an stage where no effect
on neural crest speciﬁcation is observed (Fig. 4S). When Edn1 or
BQ123 were added at stage 18 a clear effect in neural crest migration
was observed (Fig. 10E; 61% with more migration, n=34; Fig. 10H;
Fig. 10. Edn1/Ednra signaling is required for neural crest migration. (A–C) One dorsal blastomere of a 4–8-cell embryo was injected with 20 ng/embryos EdnraMO (A). EdnraMO-
injected side (B) show arrested neural crest migration. Note FoxD3-expressing neural crest cells accumulated lateral to the hindbrain. (D, G) Embryos were grafted before the onset of
neural crest migration (St. 18) with Edn1- or BQ123-soaked beads, ﬁxed between St. 21–23, and the expression of Snail2 or FoxD3 analyzed. The midline (upper line) and the leading
edge of migration are indicated by broken lines. Embryos grafted with Edn1-soaked beads show an increased neural crest migration (E). Embryos grafted with BQ123-soaked bead
show inhibition of neural crest migration (H). (C, F, I) Control side showing normal neural crest migration.
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indicate that Edn1/Ednra signaling regulates the migration of neural
crest cells.
Discussion
The development of neural crest is mediated by complex interac-
tions of multiple signals and transcription factors. In this study, we
show that the early induction, migration and maintenance of neural
crest speciﬁcation require the Edn1/Ednra signaling pathway.
We report here the isolation of the Xenopus laevis Ednra cDNA.
Following the comparison with Ednra molecules from different
species, this transcript has shown to be different from the Endothelin
receptor (ETAX) previously isolated from Xenopus heart (Kumar et al.,
1994), and Edrnb or Ednrc (Karne et al., 1993), and probably represents
a different isotype or an isoform expressed during embryonic
development. In addition, we were able to identify Xenopus tropicalis
Ednra gene from genomic sequence in order to expand our
phylogenetic analysis. Either Ednra mRNAs sequences or gene
structures for this species and human Ednra (Livingston et al., 2004)
demonstrated to be highly conserved.Xenopus laevis Ednra is expressed in the prospective cranial and
trunk neural crest from late gastrula stage (St. 12.5). The onset of
Ednra expression is not as early as other genes expressed in the
neural crest like Snail1 (Aybar et al., 2003; Essex et al., 1993; Linker
et al., 2000; Mayor et al., 1993), Msx1 (Suzuki et al., 1997; Tribulo
et al., 2003) or Pax3 (Bang et al., 1997), and it is occurring
simultaneously to Snail2 (Aybar et al., 2003; Mayor et al., 1995;
O'Donnell et al., 2006) and FoxD3 (O'Donnell et al., 2006; Sasai et
al., 2001), and much earlier than Sox10 (Aoki et al., 2003; Honore
et al., 2003). In mouse embryos, Ednra is expressed by migrating
cranial neural crest cells and by the cephalic neural crest-derived
ectomesenchyme of the pharyngeal arches (Clouthier et al., 1998;
Yanagisawa et al., 1998a). In chicken embryos, Ednra expression
appears ﬁrst in the mesectodermal cells surrounding the arteries of
branchial arches (Kempf et al., 1998; Nataf et al., 1998). Recently,
Ednra was cloned in zebraﬁsh and the in situ hybridization analysis
revealed that Ednra is ﬁrst expressed in the neural crest cells
during migration (Nair et al., 2007). The analysis of Edn1 (suc/et1)
expression pattern and functional studies indicate that Edn1/Ednra
cell signaling pathway is involved in the pharyngeal arches formation
(Miller et al., 2000, 2003). In conclusion, the early expression of Ednra
Fig. 11.Model for the early role of Edn1/Ednra signaling in Xenopus embryo neural crest
speciﬁcation. (A) During early neural crest induction (stages 12–14, gastrula-early
neurula), Msx1 is expressed in the neural fold and works upstream of Ednra; while
Ednra is upstream of Snail2, Sox9 and Sox10. (B) During mid-neurula to late neurula
stages, the activity of Edn1/Ednra signaling is required for neural crest maintenance and
for cell survival. The intermediate mesoderm is the source of Edn1.
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in other animal models, however we cannot rule out the possibility
that low levels of this receptor are expressed in other systems but are
hard to detect.
The Ednra expression in neural crest progenitors prompted us to
examine the role Edn1/Ednra signaling pathway plays in the neural
crest speciﬁcation in Xenopus embryos. Ednra knockdown using a
speciﬁc morpholino oligonucleotide or the pharmacological inactiva-
tion of Ednra produced depletion of neural crest precursors. On the
contrary, the overexpression of Ednra or the Edn1-peptide ligand
produced an increase in the neural crest cell population. In our
experiments, the changes in neural crest territory are accompanied by
compensatory expansion or reduction in the neural plate and the
epidermal domains. This suggests that Ednra activity lead to a fate
transformation of cells contiguous to the neural crest that is consistent
with the idea of neural crest competence territory (Bastidas et al.,
2004).
To further understand the participation of Edn1/Ednra signaling in
neural crest development, we examined the temporal requirement of
this signaling pathway during neural crest speciﬁcation. It has been
established for Xenopus embryos that ectoderm is competent to form
neural crest cells from stages 10–12, and that neural crest cells are
speciﬁed from stage 13, although a loss of Snail2 signal was reported
at stage 17 (Mancilla andMayor,1996). Our in vivo results, using Edn1-
or BQ123 soaked bead grafted at stage 14, show that the activity of
Edn1/Ednra signaling is continuously required and suggest that the
speciﬁcation process is still not ﬁnished. A possible explanation to
these observations is that neural crest explants dissected at stage 13
(Mancilla and Mayor, 1996) received an initial priming of Edn1 signal
enough to maintain some Snail2 expression. In our study, the use of an
Ednra blocking reagent like BQ123 revealed this requirement of Edn1
as a maintenance signal.
It is known that mesodermal tissue from the dorsolateral marginal
zone (DLMZ) is required for the induction of Xenopus neural crest
(Bonstein et al., 1998; Mancilla and Mayor, 1996; Marchant et al.,
1998), although the involution of this tissue is dispensable for
zebraﬁsh neural crest induction (Ragland, Raible, 2004). Here, we
show that lateral mesodermal tissue is required for the maintenance
of the neural crest speciﬁcation and for cell survival during mid-
neurula stages, and that it might be the source of Edn1 signal. Ednra
lies downstream Msx1 at earlier stages and in the mid-neurula stages
is required for cell survival as was demonstrated in vivo and in vitro.
The participation of Edn1/Ednra signaling in the control of apoptosis
during neural crest development could be interpreted on the basis of
its requirement for the expression of Snail2 and Sox10, two genes that
function as survival factors in the neural crest (Honore et al., 2003;
Tribulo et al., 2004). Probably, a cascade Edn1–Ednra–Snail2 might
function to control cell survival in the neural crest. Alternatively, the
activity of Ednra might activate a Snail2-independent intracellular
cascade to repress the apoptotic machinery. However, this aspect of
Edn1/Ednra signaling during embryonic development still remains to
be unraveled.
Themaintenance of neural crest precursors could occur by keeping
them from cell death or by maintaining their speciﬁcation state as
well. Our results favor a double role for Edn1/Ednra signaling in
controlling both processes during mid- to late neurula stages. We
were able to dissociate the effects of inhibition of Edn1/Ednra
signaling on apoptosis from cell speciﬁcation through the over-
expresion of a Snail2-inducible construct and expression of XBcl2.
Snail2 is unable to induce the expression of speciﬁcation markers
during mid-neurula stages, and has demonstrated to act as an anti-
apoptotic factor both in vivo as in neural crest explants (Tribulo et al.,
2004; this work). When Snail2GR- or XBcl2-injected neural crest
explants were cultured from stage 16 until stage 22 in the absence of
mesoderm or when Edn1/Ednra pathway was inhibited, FoxD3 and
Snail2 markers were lost, and this was not due to a cell death processthat eliminated the neural crest cells from the explant. Our ﬁndings
emphasize the role of the mesoderm and indicate that Edn1/Ednra
signaling pathway controls cell survival and maintenance of speciﬁca-
tion processes independently. However, this does not rule out the
possibility that both processes are simultaneously occurring in vivo, or
that for neural crest cells is necessary to survive ﬁrst and then to
maintain its speciﬁcation status. Thus, our results suggest that Edn1/
Ednra signaling controls a complex regulatory network that probably
coordinates the action of other neural crest maintenance factors such
as Id3 (Light et al., 2005) or Sox10 (Kim et al., 2003; Paratore et al.,
2002).
Ednra is expressed continuously during stages 18–23 by the
migrating population of neural crest cells in Xenopus embryos. This
feature also is evident inmouse embryos, although Ednra-null mice do
not have defects on cephalic and cardiac neural crest migration
(Clouthier et al., 1998, 2003; Yanagisawa et al., 1998a). Chick embryos
do not express Ednra in the migrating neural crest cells (Kempf et al.,
1998; Nataf et al., 1998), and it has been demonstrated that Edn1
exclusively controls postmigratory neural crest development in the
zebraﬁsh embryo (Kimmel et al., 2003; Miller and Kimmel, 2001;
Miller et al., 2000, 2003). Here we showed that Edn1/Ednra signaling
is required for neural crest migration.
The temporal appearance of Ednra expression suggests that it
could be controlled by genes expressed earlier in the neural crest. As
Msx1 is one of the earliest transcription factors in the genetic cascade
of neural crest speciﬁcation (Monsoro-Burq et al., 2005; Tribulo et al.,
2003) we investigated the hierarchical relationship between these
two genes. It has been established for the developing branchial arch of
mouse embryos that HAND genes are mediators of Edn1/Ednra
signaling and control the expression of Msx1 (Thomas et al., 1998)
probably by its binding to a selective enhancer that control ﬁrst
branchial arch expression (MacKenzie et al., 1997). Our ﬁndings show
that the relationship of both genes is reverse during Xenopus neural
crest initial speciﬁcation, since the activation of an Msx1 inducible
construct (Msx1-GR) at the initial moment of neural crest speciﬁcation
leads to an increase in neural crest markers (Tribulo et al., 2003; this
work) and Ednra expression. Furthermore, Ednra is able to rescue the
dominant negative of Msx1 (HDMsx1-GR), and EdnraMO blocks the
128 M. Bonano et al. / Developmental Biology 323 (2008) 114–129Msx1-induced neural crest expansion. Altogether, these epistatic
experiments indicate that Msx1 lays upstream Ednra in the neural
crest speciﬁcation cascade. However, overexpression of Msx1 do not
induce ectopic expression of Ednra or general neural crest markers far
from the neural fold region (Tribulo et al., 2003), or within the neural
plate or the epidermis indicating that additional factors are required
for neural crest speciﬁcation. In addition to show that Msx1 works
upstream of Ednra, we also present evidence that indicates that Sox9
and Sox10 are downstream of Edn1/Ednra signaling. Taken together
the followingmodel of neural crest development can be proposed (Fig.
11). The inductive signals (BMP, Wnts, FGF and RA) transform the
ectoderm into neural plate border, which expresses the Neural Plate
Border Speciﬁer Genes (e.g.Msx1; see Meulemans and Bronner-Fraser,
2004; Steventon et al., 2005). These genes control the expression of
the Neural Crest Speciﬁers (e.g. Snail2, FoxD3, Sox9 and Sox10),
including Ednra. Once the Ednra gene is expressed, the neural crest
can respond to Edn1 secreted by the mesoderm underlying the neural
crest. The activation of the Edn1/Ednra pathway is required for the
speciﬁcation of the neural crest and for the maintenance of several
Neural Crest Speciﬁer Genes.
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